The heart rate response to succinylcholine in children: A comparison of atropine and glycopyrrolate (6, 10, 15, 20 seconds) between injection of atropine or glyeopyrrolate and succinylcholine.
Bradycardia and asystole have been reported after administration of succinyleholine to children) 'z Although succinylcholine-induced bradycardias are usually transient, there have been reports of prolonged periods of bradycardia and short periods of asystole after a bolus dose of succinyleholine.l-4 In order to prevent these dysrhythmias, we frequently administer intravenous atropine before giving succinylcholine.
Glycopyrrolate (Robinul), a new antimuscarinic drug, produces less tachycardia, less cen~al nervous system excitement, and greater xerostomia than atropine. 5-7 Although one group showed that inffavenous glycopyrrolate was as effective as atropine in preventing suecinylcholine-induced heart rate changes in children, 7 they did not compare the heart rate responses to suecinylcholine immediately after adminisFation of succinylcholine. Because the onset of bradycardias occurs within 20 seconds after an intravenous bolus of succinylcholine, 2 we recorded the heart rate for 24 seconds before and 54 seconds after administration of suecinylcholine to children who were pretreated with intravenous atropine or glycopyrrolate.
Methods
We studied 40 unmedicated children, ages 1-7 years, scheduled for elective ophthalmic or tonsil surgery. All patients were ASA physical status I. Prior to induction of anaesthesia, each patient was assigned to either Group I (atropine) or Group II (glycopyrrolate).
General anaesthesia was induced using thiopentone (5 mg'kg-5, atropine (0.02 mg.kg -z) or glycopyrrolate (0.01 mg.kg -1) and succinylcholine CAN ANAESTH SOC J 1983 ,' 30:4/pp377-381 
FIGURE 1
The experimental protocol. A represents the administration of thiopentone, B. the change of syringes, and C, the administration o~ e atropine or glyeopyrrelate. El, E2, E3. E4 are ~ub~r0ups in which the interval between administration of atropine or glycopyrrol~te and succinylcholine was 6, 10, 15 and 20 seconds respectis'ely~ (2 mg.kg -j) each injected separately through a #25 gauge needle inserted into a dorsal vein of the hand. Each drug was diluted with sterile water to a specified volume (thiopentone 5 ml and the others 2~). The experimental protocol was divided into an induction period (the first 24 seconds) and an experimental period (the subsequent 54 seconds) ( Figure 1 ). The induction period consisted of three steps: (A) injection ofthiopentone (12 seconds), (B) change of syringes (six seconds) and (C) injection of atropine or glycopyrrolate (six seconds). After the induction period, each group was further divided into four subgroups. The subgroups (El, E2, E3, E4) differed only in the interval between the injection of atropine or glycopyrrolate and the injection of the succinylcholine (6, 10, 15, 20 respectively). The experimental period was followed by intubation, ventilation and surgery.
We recorded an electrocardiographic (lead ll) tracing during the pre-induction period (control heart rate) and continuously for the first 78 seconds of anaesthesia. We measured the heart rates from the R-R intervals. After determining the control heart rate for each patient, we calculated the per cent change in heart rate from control for each patient every three seconds for the duration of the experimental protocol. The per cent change in heart rate from control during the induction period was the mean per cent change for all four subgroups combined, whereas that per cent change during the expenmental period was the mean per cent change for each subgroup.
We defined bradycardia as a heart rate less than 60 beats/rain. We determined the incidence of both bradycardias and heart rates more than 20 per cent below control heart rate, during the period immediately after suecinyleholine.
Statistical comparisons were made with an unpaired Bonferonni t test s and a Chi-Square Analysis with the Yates correction. A significance level of P < 0.05 was accepted.
This study was approved by the Human Experimentation Committee at the Hospital for Sick Children, Toronto, Ontario.
Results
The ages and weights (mean + SE) of the patients in groups I and 11:4.15 • 0.4 years and 16.3 --+ i. 1 kg, and 3.78 -0.5 years and 15.4.4-1.7 kg respectively, were not significantly different. The preinduction heart rates (mean -+ SE) for the 2 groups: 134 -+ 6.6 beatstmin and 141 ---8.8 beats/rain respectively, were significantly different from the mean resting (ward) heart rate of 105 beat~/min (P < 0.05). During the induction period, the mean heart :rates of both groups were not significantly different from the control heart rate. During the experimental period, the mean heart rate of each subgroup decreased initially to the control heart rate or lower and then increased to control or higher (Figs. 2, 3) . We found no difference in either the *Per cent change in heart rate from control heart rate. The subgroups El+ E2, E3, E4 differ in the interval between injection of atropine or glycopyrrolate and suceinylc holine (6, 10, 15 and 20 seconds respectively). There was no significant difference between subgroups for either heart rate measurement.
magnitude or the duration of the decrease in heart rate or the subsequent increase in heart rate between respective subgroups (Table) . There was no significant difference between the number of patients in respective subgroups whose heart rate decreased more than 20 per cent below control during the experimental period. The incidence of bradycardias in Groups I and I1, 0/20 and 2/20 respectively, was not significantly different. Although both bradycardias occurred in patients receiving glycopyrrolate, in neither case did the heart rate decrease below 55 beats/min, last longer than ten seconds or change rhythm. Both bradycardias resolved spontaneously without any intervention.
Discussion
In the present study, we found that the new antimuscarinic agent, glycopyrrolate ((3.01 mg'kg-1), was as effective as atropine (0.02mg-kg -=) in attenuating succinylcholine-induced heart rate changes and bradycardias during the 54 seconds immediately after administration of succinylcholine. These results agree with previous studies which demonstrated that the antimuscarinic properties of glycopyrrolate were as effective as those of nil-opine. 5-7
Previous investigators reported succinylcholineinduced slowing of the heart rate when the heart rate decreased more than 15 percent below control heart rate, 9 or more than 20 per cent below control 2 or if the absolute heart rate was less than 60 beats/min (bradyeardia). I~ The definition of a clinically important slowing of the heart rate (bradycardia) in newborns, is a heart rate less t.han 80 beats/rain 13 and in adults, it is a heart rate less than 60 beats/min. In children, however, the definition of bradycardia and the crucial heart rate at which significant circulatory embarrassment occurs is less well defined. Therefore, we examined the incidence of both bradycardias and heart rates more than 20 per cent below control in both treatment groups and found no significant difference in either heart rate response between atropine and glycopyrrolate.
We found no difference in the speed of onset of atropine and glycopyrrolate in blocking succinylcholine-induced heart rate changes. Although glycopyrrolate is a quaternary ammonium compound and might therefore be expected to take longer to effect blockade of the sinus node than atropine, a tertiary ammonium compound, we were unable to detect any significant difference in the onset of action between atropine and glycopyrrolatr particularly when the interval between injection of atropine or glyeopyrrolate and suceinylcholine was only six seconds.
Thiopentone has been reported to protect against succinylcholine-induced bradycardias, z'l~ The small incidence of bradycardias reported here might be explained by the combined protection of thiopentone and the antimuscarinic drugs. Because we did not believe that the administration of thiopentone and succinylcholine without an antimusearinic drug was acceptable practice at our institution, we could not determine the importance of thiopentone in protecting against succinylcholine-induced heart rate changes. Therefore, in the presence of thiopentone, we found that atropine and glycopyrrolate were equally effective in attenuating snccinylcholine-induced bradycardias.
Although the resting (ward) and ple-induction heart rates were within normal limits for children ages one to seven years, 13 the pre-induction heart rates were significantly higher (P < 0.05) than the resting values. An increased pre-induction heart rate in unmedicated children, who are experiencing the stress of hospitalization, parental separation and the fear of the needle is common. Because preinduction heart rates were significantly higher than the resting values, the transient decreases in heart rate to 20 per cent below control recorded in some patients, was acceptable (heart rates of 115 beats/ min).
In summary, we found that in the presence of thiopentone, atropine (0.02mg.kg -I) and glycopyrrnlate (0.01 mg-kg -1) are equally effective in attenuating suecinylcholine-indueed decreases in heart rate in children.
